Anna Tayebnejad
Papers
1
Total Citations
133
H-Index
1
About
Dr. Anna Tayebnejad is a leading researcher in gynecologic oncology, with a focused expertise in optimizing perioperative care and thromboembolism prevention. Her most cited work, a 2020 study with 133 citations, directly challenges current clinical guidelines by evaluating the safety and efficacy of apixaban versus enoxaparin for preventing postoperative venous thromboembolism in women undergoing surgery for gynecologic malignant neoplasms. This pivotal research addresses a critical gap in patient care, as the standard 28-day enoxaparin course is often hampered by high costs and low adherence. By demonstrating the potential of a more patient-friendly oral alternative, Dr. Tayebnejad’s contributions are shaping safer, more accessible thromboprophylaxis strategies. Her work not only highlights a deep commitment to improving surgical outcomes but also provides a strong evidence base for future practice changes. For students and researchers, her studies exemplify how targeted clinical research can directly translate into meaningful improvements in the quality of life and safety for cancer patients.
Research Focus
Key Achievements
Top Papers
- 1